Ardolita - Company finances
|
EUR
|
2019
From: 2019-07-29
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 7,058 | 6,200 | 8,760 | 2,454 | 40,788 | 29,151 | 100,557 |
| Profit before tax | 6,405 | 5,081 | 1,973 | -1,626 | 27,475 | -5,964 | 47,113 |
| Net profit | 6,085 | 4,827 | 1,871 | -1,626 | 26,101 | -5,964 | 44,286 |
| Equity | 6,285 | 11,432 | 14,272 | 11,296 | 26,351 | 20,388 | 64,674 |
| Liabilities | - | - | 1,927 | 1,193 | 11,333 | 16,933 | 21,878 |
| Non-current assets | 1,059 | 696 | 333 | 1 | 686 | 2,889 | 4,052 |
| Current assets | 7,285 | 11,614 | 15,866 | 12,488 | 36,998 | 34,432 | 82,500 |
| Total assets | 8,344 | 12,310 | 16,199 | 12,489 | 37,684 | 37,321 | 86,552 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 840 | 2,290 | 1,996 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | -12.2% | +41.3% | -72.0% | +1562.1% | -28.5% | +245.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 72.9% | 39.2% | 11.6% | -13.0% | 69.3% | -16.0% | 51.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.8% | 42.2% | 13.1% | -14.4% | 99.1% | -29.3% | 68.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 86.2% | 77.9% | 21.4% | -66.3% | 64.0% | -20.5% | 44.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 90.7% | 82.0% | 22.5% | -66.3% | 67.4% | -20.5% | 46.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.1 | 0.1 | 0.4 | 0.8 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ardolita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-03 | 2024-04-30 | 64.50 |
| 2024-03-01 | 2024-03-31 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2024-01-03 | 2024-01-31 | 175.89 |
| 2023-12-01 | 2024-01-02 | 117.26 |
| 2023-11-03 | 2023-11-30 | 58.63 |
Ardolita - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Ardolita is: 5 €
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-09-02 | 4.53 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ardolita, MB (code 305218237) is a Small partnership engaged in research and development in medical sciences. In the latest financial year, 2025, the company reported revenue of €100.6K and net profit of €44.3K, corresponding to a profit margin of 44.0%. This represents strong improvement from 2024, when revenue fell to €29.2K and the company posted a net loss of €6.0K after a profitable 2023. Over the 2023–2025 period, revenue moved from €40.8K to €29.2K and then rose sharply to €100.6K, while net profit shifted from €26.1K in 2023 to a loss in 2024 and then recovered strongly in 2025. At year-end 2025, total assets stood at €86.6K, equity at €64.7K, and liabilities at €21.9K, indicating a solid equity position with an equity ratio of 74.7%. Key efficiency indicators also point to strong performance, with ROE at 68.5%, ROA at 51.2%, debt-to-equity at 0.34, and asset turnover at 1.16x.